Cancer in the elderly: Tailoring treatment

被引：5

作者：

Balducci, L ^{[1
]}

Carbone, PP ^{[1
]}

机构：

[1] Univ S Florida, Coll Med, Tampa, FL 33620 USA

来源：

HOSPITAL PRACTICE | 2000年 / 35卷 / 03期

关键词：

D O I：

10.3810/hp.2000.03.187

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The body's ability to meet the stresses of cancer therapy declines in later life. Because the decline may vary from minimal to profound and is only weakly linked to chronologic age, a thorough functional assessment should be undertaken in all elderly cancer patients. The results can guide decisions about how to treat the cancer.

引用

收藏

页码：73 / 80

页数：8

相关论文

共 9 条

[1]

Balducci L, 1997, CANCER, V80, P1317, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1317::AID-CNCR18>3.3.CO

[2]

2-I

[3] BREAST-CANCER IN ELDERLY WOMEN - A CANCER-RESEARCH CAMPAIGN TRIAL COMPARING TREATMENT WITH TAMOXIFEN AND OPTIMAL SURGERY WITH TAMOXIFEN ALONE [J].

BATES, T ;

RILEY, DL ;

HOUGHTON, J ;

FALLOWFIELD, L ;

BAUM, M .

BRITISH JOURNAL OF SURGERY, 1991, 78 (05) :591-594

[4] Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study [J].

Demetri, GD ;

Kris, M ;

Wade, J ;

Degos, L ;

Cella, D .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3412-3425

[5] Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor:: Identification of two age subgroups with differing hematologic toxicity [J].

Gómez, H ;

Mas, L ;

Casanova, L ;

Pen, DLK ;

Santillana, S ;

Valdivia, S ;

Otero, J ;

Rodriguez, W ;

Carracedo, C ;

Vallejos, C .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) :2352-2358

[6] Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: Results of a randomized comparison [J].

Pierelli, L ;

Perillo, A ;

Greggi, S ;

Salerno, G ;

Panici, PB ;

Menichella, G ;

Fattorossi, A ;

Leone, G ;

Mancuso, S ;

Scambia, G .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1288-1295

[7] Features of cancer in nonagenarians and centenarians [J].

Saltzstein, SL ;

Behling, CA ;

Baergen, RN .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (08) :994-998

[8] CHOP is the standard regimen in patients ≥70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma:: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group [J].

Tirelli, U ;

Errante, D ;

Van Glabbeke, M ;

Teodorovic, I ;

Kluin-Nelemans, JC ;

Thomas, J ;

Bron, D ;

Rosti, G ;

Somers, R ;

Zagonel, V ;

Noordijk, EM .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :27-34

[9]

Zinzani PL, 1997, BLOOD, V89, P3974